Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05155423 · ClinicalTrials.gov registry record
A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy
A clinical trial of Spinal Metastases, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 21
- Enrollment target
- 1
- Study location
NCT05155423: Active study of Spinal Metastases, sponsored by M.D. Anderson Cancer Center.
NCT05155423 is a study of Spinal Metastases that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 21 participants, below the 114-participant average among 5 other Spinal Metastases trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05155423, a study of Spinal Metastases, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn the usefulness of performing MRI scans in different positions and learn the best practice for spinal stereotactic body radiation therapy (spinal SBRT) planning and dose delivery.
Conditions Studied
Interventions
- OTHER mask for immobilization
- OTHER Elekta BodyFix
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-04-21 |
| Est. Completion | 2026-05-24 |
What the registry record for NCT05155423 still lists
NCT05155423 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 114-participant average among 5 other Spinal Metastases trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Spinal Metastases appearing as the primary indexed condition, and to 2 interventions - of which mask for immobilization is the first listed.
NCT05155423 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05155423 about?
NCT05155423 is a clinical study titled "A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy". To learn the usefulness of performing MRI scans in different positions and learn the best practice for spinal stereotactic body radiation therapy (spinal SBRT) planning and dose delivery.
What is the current status of trial NCT05155423?
This trial is currently active not recruiting. The enrollment target is 21 participants. The study started on 2018-04-21. Estimated completion is 2026-05-24.
What conditions does trial NCT05155423 study?
This clinical trial studies the following conditions: Spinal Metastases.
What interventions are being tested in trial NCT05155423?
The interventions under investigation include: mask for immobilization (OTHER), Elekta BodyFix (OTHER).
Who is sponsoring clinical trial NCT05155423?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05155423 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
D20054;LITT for Spine Tumors
RECRUITING · NA
-
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
RECRUITING · Phase 3
-
Validation of Novel Predictive Score for Patients With Spinal Metastases
COMPLETED
-
Intra-arterial Chemotherapy for Spinal Metastases
COMPLETED · Phase 1
-
Stereotactic Body Radiotherapy for Spine Tumors
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI